Gainers & Losers
Tue Mar 17 2026 09:55:54- Eternal share price
- ₹234.105.43%
- Tata Steel share price
- ₹194.954.17%
- Mahindra & Mahindra Ltd share price
- ₹3,125.002.94%
- Bharat Electronics share price
- ₹439.452.34%
- Larsen & Toubro Ltd share price
- ₹3,543.502.30%
Active Stocks
Tue Mar 17 2026 10:27:31- Eternal share price
- ₹234.705.70%
- REC share price
- ₹337.501.56%
- Yes Bank share price
- ₹18.640.49%
- Suzlon Energy share price
- ₹41.210.49%
- Tata Steel share price
- ₹195.404.41%
Business News/Market/Market Stats/Remus Pharmaceuticals share price/ Remus Pharmaceuticals Cash Flow Annual
Remus Pharmaceuticals Cash Flow Annual
679.90 -8.60 (-1.25%)Updated : 17 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 8.75 | -6.50 | 7.75 | -0.09 |
| Net Changein Cash | 2.51 | 19.03 | 1.89 | 0.32 |
| Cash Taxes Paid | 7.47 | 6.57 | 3.00 | 1.19 |
| Net Income/ Starting Line | 47.34 | 31.83 | 11.41 | 4.55 |
| Total Cash Dividends Paid | -1.18 | -0.59 | - | - |
| Changesin Working Capital | -40.58 | -27.45 | -6.27 | 0.49 |
| Cashfrom Operating Activities | 6.99 | 3.60 | 5.31 | 5.04 |
| Cash Interest Paid | 1.46 | 0.48 | 0.23 | 0.09 |
| Cashfrom Financing Activities | 6.07 | 24.37 | 11.77 | -0.17 |
| Depreciation/ Depletion | 1.87 | 0.90 | 0.48 | 0.15 |
| Other Investing Cash Flow Items Total | -6.57 | -8.31 | -12.46 | -4.47 |
| Capital Expenditures | -3.98 | -0.64 | -2.73 | -0.07 |
| period Type | - | - | - | - |
| Non- Cash Items | -1.64 | -1.67 | -0.31 | -0.16 |
| Financing Cash Flow Items | -1.50 | -16.23 | -0.23 | -0.09 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -10.55 | -8.94 | -15.19 | -4.55 |
| Issuance( Retirement)of Stock Net | - | 47.69 | 4.25 | 0.00 |
*All figures in crores except per share values
Remus Pharmaceuticals Quick Links
Remus Pharmaceuticals Dividend Remus Pharmaceuticals Bonus Remus Pharmaceuticals News Remus Pharmaceuticals AGM Remus Pharmaceuticals Rights Remus Pharmaceuticals Splits Remus Pharmaceuticals Board Meetings Remus Pharmaceuticals Key Metrics Remus Pharmaceuticals Shareholdings Remus Pharmaceuticals Profit Loss Remus Pharmaceuticals Balance Sheet Remus Pharmaceuticals Q1 Results Remus Pharmaceuticals Q2 Results Remus Pharmaceuticals Q3 Results Remus Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
236.00+13.95(6.28%)
195.50+8.35(4.46%)
3,132.20+96.50(3.18%)
1,234.80-14.80 (-1.18%)
871.00-7.90 (-0.90%)